The AUC value for alpha-defensin was 0.78 ± 0.06 (95% CI = 0.66 to 0.89, p<0.0002), suggesting that DEFA1 levels could act as a potential biomarker in predicting disease severity in COVID-19. This evidence concerns the gene DEFA1 and COVID-19.